215 studies found for:    "Eye Diseases, Hereditary" OR "Lenz microphthalmia syndrome"
Show Display Options
Rank Status Study
21 Recruiting Descemet Membrane Endothelial Keratoplasty (DMEK)
Condition: Corneal Dystrophies, Hereditary
Intervention: Procedure: Descemet Membrane Endothelial Keratoplasty (DMEK)
22 Recruiting Rituximab (RTX) Therapy in Patients With Active TAO
Condition: Ophthalmopathy, Thyroid-Associated
Interventions: Drug: Rituximab;   Drug: Iv Methylprednisolone;   Drug: peroral methylprednisolone and Methotrexate
23 Recruiting Comparison of Two Techniques in Achieving Corneal Graft
Condition: Fuch's Endothelial Dystrophy
Intervention: Procedure: Endothelial descemet membrane graft
24 Recruiting Novel Diagnostics With Optical Coherence Tomography: Imaging the Anterior Eye
Conditions: Fuch's Dystrophy;   Corneal Disorders;   Prior Surgery
Intervention:
25 Completed Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone Injections
Condition: Thyroid-associated Ophthalmopathy
Intervention: Drug: subconjunctival triamcinolone injection
26 Unknown  Comparing Endoglide to Endoserter for DSAEK Graft Insertion
Conditions: Fuch's Endothelial Dystrophy;   Bullous Keratopathy, Unspecified Eye
Interventions: Device: Tan Endoglide;   Device: Endosaver
27 Terminated A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: CNTO 2476
28 Recruiting Biomarkers In Retinitis Pigmentosa (BIRP)
Condition: Retinitis Pigmentosa Patients
Intervention: Other: AC tap
29 Recruiting Clinical, Cellular, and Molecular Investigation Into Oculocutaneous Albinism
Conditions: Albinism;   Oculocutaneous Albinism;   Foveal Hypoplasia;   Hypopigmentation;   Nystagmus
Intervention:
30 Not yet recruiting The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.
Conditions: Thyroid Eye Disease;   Ocular Hypertension;   Glaucoma
Interventions: Drug: Prostaglandin Analog;   Drug: Timolol
31 Completed Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65)
Condition: Retinitis Pigmentosa (RP)
Intervention: Drug: QLT091001
32 Recruiting Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy (LHON) Caused by the G11778A Mutation
Conditions: Leber's Hereditary Optic Neuropathy;   G11778A Gene Mutation;   Human Mitochondrial ND4 Gene
Interventions: Drug: scAAV2-P1ND4v2 5.00x10e9 vg (Low),;   Drug: scAAV2-P1ND4v2 2.46X10e10 vg (Med);   Drug: scAAV2-P1ND4v2 1.0X10e11vg (High)
33 Unknown  IRIS PILOT - Extended Pilot Study With a Retinal Implant System
Conditions: Retinitis Pigmentosa;   Cone-Rod Dystrophy;   Choroideremia
Intervention: Device: Retinal Implant System (IRIS)
34 Completed A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: NT-501
35 Completed The Role of Capsular Tension Ring (CTR) in Anterior Capsular Contraction
Conditions: Retinitis Pigmentosa;   Cataract
Intervention: Procedure: IOL surgery
36 Completed Rituximab in the Treatment of Graves' Disease
Conditions: Graves´ Disease;   Thyroid Associated Ophthalmopathy
Interventions: Drug: Methimazole;   Drug: Rituximab;   Biological: Immunization with various vaccines
37 Recruiting Study of Endothelial Keratoplasty Outcomes
Conditions: Fuchs' Endothelial Corneal Dystrophy;   Bullous Keratopathy;   Iridocorneal Endothelial Syndrome;   Posterior Polymorphous Dystrophy
Intervention: Procedure: endothelial keratoplasty
38 Unknown  Cornea Donor Study
Conditions: Corneal Disease;   Fuch's Dystrophy;   Pseudophakic Corneal Edema
Intervention: Other: corneas assigned by donor age group
39 Recruiting Study of Selected X-Linked Disorders: Aicardi Syndrome
Conditions: Aicardi Syndrome;   Brain Disorders
Intervention:
40 Enrolling by invitation A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of UshStat® in Patients With Usher Syndrome Type 1B
Condition: Usher Syndrome
Intervention: Drug: UshStat

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years